← Back to home

THROMBOCYTOPENIA IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING ELECTIVE INVASIVE SURGERY

Clinical trials for THROMBOCYTOPENIA IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING ELECTIVE INVASIVE SURGERY explained in plain language.

Never miss a new study

Get alerted when new THROMBOCYTOPENIA IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING ELECTIVE INVASIVE SURGERY trials appear

Sign up with your email to follow new studies for THROMBOCYTOPENIA IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING ELECTIVE INVASIVE SURGERY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to help liver patients undergo surgery safely

Disease control Recruiting now

This study is testing if a drug called Herombopag can safely increase platelet counts in people with chronic liver disease who need elective surgery. Low platelets increase bleeding risk during procedures. The goal is to see if the drug can raise counts enough to avoid needing pl…

Matched conditions: THROMBOCYTOPENIA IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING ELECTIVE INVASIVE SURGERY

Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

THROMBOCYTOPENIA IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING ELECTIVE INVASIVE SURGERY

Get alerted when new THROMBOCYTOPENIA IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING ELECTIVE INVASIVE SURGERY trials appear

New drug trial aims to help liver patients undergo surgery safely